IT1254216B - Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono - Google Patents
Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengonoInfo
- Publication number
- IT1254216B IT1254216B ITMI920405A ITMI920405A IT1254216B IT 1254216 B IT1254216 B IT 1254216B IT MI920405 A ITMI920405 A IT MI920405A IT MI920405 A ITMI920405 A IT MI920405A IT 1254216 B IT1254216 B IT 1254216B
- Authority
- IT
- Italy
- Prior art keywords
- heparin
- eparan
- sulphate
- fractions
- fragments
- Prior art date
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical class OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title abstract 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 title 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910021653 sulphate ion Inorganic materials 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 abstract 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract 1
- 102000004366 Glucosidases Human genes 0.000 abstract 1
- 108010056771 Glucosidases Proteins 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 abstract 1
- 150000002016 disaccharides Chemical class 0.000 abstract 1
- 239000002628 heparin derivative Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
Abstract
Derivati di eparina costituiti da disaccaridi di formula I (FORMULA I) [dove R1= CH3-CO (? 50%), SO3 - (? 50%); R2= O-SO3 - (? 40%), OH (? 60%); R4= SO3 -, H; n, m - numeri interi compresi tra 1 e 30;C= acido iduronico 2-OSO3 oppure acido galatturonico], ottenuti per N-desolfatazione, N-acetilazione, U-2-O-desolfatazione selettive e controllate ed inversione dei C2-C3 dell'acido uronico, dotati di attività farmacologica di inibizione di glucosidasi e complessivamente di attività antiaterosclerotica.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI920405A IT1254216B (it) | 1992-02-25 | 1992-02-25 | Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
EP93102527A EP0557887B1 (en) | 1992-02-25 | 1993-02-18 | Polysaccharide derivatives of heparin, heparan sulphate, fraction and fragments thereof, process for their preparation and pharmaceutical compositions containing them |
DE69315724T DE69315724D1 (de) | 1992-02-25 | 1993-02-18 | Polysaccharidderivate von Heparin, Heparansulfate, ihre Fraktionen und Fragmente, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, welche diese enthalten |
AT93102527T ATE161273T1 (de) | 1992-02-25 | 1993-02-18 | Polysaccharidderivate von heparin, heparansulfate, ihre fraktionen und fragmente, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, welche diese enthalten |
ES93102527T ES2110015T3 (es) | 1992-02-25 | 1993-02-18 | Derivados de polisacaridos de heparina, sulfato de heparan, sus fracciones y fragmentos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI920405A IT1254216B (it) | 1992-02-25 | 1992-02-25 | Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI920405A0 ITMI920405A0 (it) | 1992-02-25 |
ITMI920405A1 ITMI920405A1 (it) | 1993-08-25 |
IT1254216B true IT1254216B (it) | 1995-09-14 |
Family
ID=11362117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI920405A IT1254216B (it) | 1992-02-25 | 1992-02-25 | Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0557887B1 (it) |
AT (1) | ATE161273T1 (it) |
DE (1) | DE69315724D1 (it) |
ES (1) | ES2110015T3 (it) |
IT (1) | IT1254216B (it) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5668118A (en) * | 1992-07-24 | 1997-09-16 | Cavalier Pharmaceuticals | Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G |
EP1164145B1 (en) * | 1992-07-24 | 2007-12-05 | Thomas P. Kennedy | Non-anticoagulant desulfated heparins as medicaments |
US5696100A (en) * | 1992-12-22 | 1997-12-09 | Glycomed Incorporated | Method for controlling O-desulfation of heparin and compositions produced thereby |
US6127347A (en) * | 1994-01-12 | 2000-10-03 | Univ Michigan | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
US5583121A (en) * | 1994-01-12 | 1996-12-10 | Michigan State University | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
US5633233A (en) * | 1995-06-07 | 1997-05-27 | Alberta Research Council | Modified kojibiosides analogues |
CA2235223A1 (en) | 1995-10-30 | 1997-05-09 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from heparinase i |
FR2781485B1 (fr) * | 1998-07-21 | 2003-08-08 | Denis Barritault | Polymeres biocompatibles leur procede de preparation et les compositions les contenant |
US7056504B1 (en) | 1998-08-27 | 2006-06-06 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase I and II |
CA2643162C (en) | 1999-04-23 | 2018-01-02 | Massachusetts Institute Of Technology | Polymer identification, compositional analysis and sequencing, based on property comparison |
AU4351201A (en) | 2000-03-08 | 2001-09-17 | Massachusetts Inst Technology | Heparinase iii and uses thereof |
DK1319183T3 (da) | 2000-09-12 | 2009-05-18 | Massachusetts Inst Technology | Fremgangsmåder og produkter relateret til heparin med lav molekylvægt |
WO2002022122A1 (en) * | 2000-09-15 | 2002-03-21 | Novo Nordisk A/S | Use of compounds for the treatment of obesity |
CA2423469A1 (en) | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
AU2003225724A1 (en) | 2002-03-11 | 2003-09-29 | Momenta Pharmaceuticals, Inc. | Analysis of sulfated polysaccharides |
US9139876B1 (en) | 2007-05-03 | 2015-09-22 | Momenta Pharmacueticals, Inc. | Method of analyzing a preparation of a low molecular weight heparin |
US8592393B2 (en) | 2007-11-02 | 2013-11-26 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
WO2009059284A2 (en) | 2007-11-02 | 2009-05-07 | Momenta Pharmaceuticals, Inc. | Non-anticoagulant polysaccharide compositions |
US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
CN101584688B (zh) * | 2008-05-24 | 2010-11-10 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
CN101584705B (zh) * | 2008-05-24 | 2010-10-27 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
US9387256B2 (en) | 2010-04-16 | 2016-07-12 | Momenta Pharmaceuticals, Inc. | Tissue targeting |
JP5905455B2 (ja) | 2010-06-17 | 2016-04-20 | モメンタ ファーマシューティカルズ インコーポレイテッド | 発毛を促進する方法および組成物 |
US9068957B2 (en) | 2011-02-21 | 2015-06-30 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
CA3122808A1 (en) | 2012-05-09 | 2013-11-14 | Cantex Pharmaceuticals, Inc. | Treatment of myelosuppression |
WO2014193818A1 (en) | 2013-05-28 | 2014-12-04 | Momenta Pharmaceuticals, Inc. | Pharmaceutical compositions |
US10052346B2 (en) | 2015-02-17 | 2018-08-21 | Cantex Pharmaceuticals, Inc. | Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1234508B (it) * | 1988-06-10 | 1992-05-19 | Alfa Wassermann Spa | Derivati eparinici e procedimento per la loro preparazione |
IT1234826B (it) * | 1989-01-30 | 1992-05-29 | Alfa Wassermann Spa | Derivati eparinici e procedimento per la loro preparazione |
-
1992
- 1992-02-25 IT ITMI920405A patent/IT1254216B/it active
-
1993
- 1993-02-18 EP EP93102527A patent/EP0557887B1/en not_active Expired - Lifetime
- 1993-02-18 DE DE69315724T patent/DE69315724D1/de not_active Expired - Lifetime
- 1993-02-18 ES ES93102527T patent/ES2110015T3/es not_active Expired - Lifetime
- 1993-02-18 AT AT93102527T patent/ATE161273T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69315724D1 (de) | 1998-01-29 |
ITMI920405A1 (it) | 1993-08-25 |
EP0557887B1 (en) | 1997-12-17 |
EP0557887A3 (it) | 1994-02-09 |
ES2110015T3 (es) | 1998-02-01 |
EP0557887A2 (en) | 1993-09-01 |
ITMI920405A0 (it) | 1992-02-25 |
ATE161273T1 (de) | 1998-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1254216B (it) | Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
IT1214609B (it) | Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono. | |
IT1138450B (it) | Derivati dell'acido 2-idrossi-5-fenilazobenzoico,composizioni farmaceutiche che li contengono e procedimento per la loro preparazione | |
SG47517A1 (en) | (1-92-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers | |
EA199700209A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА | |
DK399588A (da) | Pentasaccharider | |
ES8206555A1 (es) | Procedimiento de preparacion de mezclas de polisacaridos sulfatados. | |
IT1229570B (it) | Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. | |
IT8548002A0 (it) | Derivati di 1,4-diidro-4-ossonaftiridina e relativi sali, procedimento per la loro produzione e agenti antibatterici che comprendono i medesimi | |
IT1223313B (it) | Derivati di acidi biliari loro preparazione e composizioni farmaceutiche che li contengono | |
HUP9902287A1 (hu) | Szintetikus poliszacharidok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
ES542125A0 (es) | Un procedimiento para preparar un derivado de 1,5-benzotiazepina. | |
IT1181741B (it) | Derivati di indolo,procedimento per prepararli e composizioni farmaceutiche che li contengono | |
IT1181705B (it) | Derivati di i,4-diidropiridina e suoi sali,procedimento per produrli e composizione farmaceutica che li contiene | |
IT8123940A0 (it) | Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo. | |
IT1229569B (it) | Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. | |
IT1182089B (it) | Derivati di indolo, procedimento, per prepararli e composizioni farmaceutiche che li contengono | |
ES2131313T3 (es) | Derivados de acido nipecotico como compuestos antitromboticos. | |
IT8148336A0 (it) | Derivati sostituiti dell'acido 4-fenil-4-osso-2-butenoico aventi proprieta' farmaceutiche | |
IT1196377B (it) | Derivati di acidi biliari,procedimento per la loro preparazione e relative composizioni farmaceutiche | |
IT1227456B (it) | Nuovi alcossi derivati di ginkgolidi, loro preparazione e composizioni terapeutiche che li contengono | |
IT1144654B (it) | Nuovi derivati dell'acido lignosolfonico,procedimento per la loro preparazione e loro utilizzazione come additivi per fanghi di perforazione | |
IT1201497B (it) | Derivati tienopiridinici,procedimento per la loro preparazione e composizioni terapeutiche che li contengono | |
IT8921513A0 (it) | Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmacuetiche che li contengono. | |
IT8023601A0 (it) | Derivati ammidici dell'acido p-isobutilfenilpropionico, procedimento per la loro preparazione e relative composizioni farmaceutici. |